Scholar Commonsmetadata only
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma
pediatric funeral services, funeral professionals, child death, pediatric palliative care, bereavement support, grieving families, needs assessment, funeral directors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 393550
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.